查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1344549

脊髓刺激 (SCS) 設備市場：按產品、按適應症、按最終用戶：2023-2032 年全球機會分析和產業預測

Spinal Cord Stimulation Devices Market By Product, By Indication, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 258 Pages | 商品交期: 2-3個工作天內

價格

根據 Allied Market Research 發布的最新報告，2022 年 脊髓刺激 (SCS) 設備市場價值為 21 億美元，2023 年至 2032 年複合年增長率為 8.4%，2022 年將達到 48 億美元。2032 年。 ，預計將達到10億美元。

脊髓刺激設備市場-IMG1

推動脊髓刺激器市場成長的主要因素是患有慢性疼痛的人數不斷增加、脊髓刺激 (SCS) 設備的技術進步以及脊髓刺激器的採用不斷增加。 慢性疼痛可由多種原因引起，包括術後脊椎疼痛症候群 (FBSS)、複雜性區域疼痛症候群 (CRPS)、退化性椎間盤疾病 (DDD) 和糖尿病神經病變。 這些情況可能會使人衰弱，影響人們的生活質量，並且需要長期管理。 脊髓刺激（SCS）設備正在成為一種有效的治療選擇，適用於其他治療方法無效的慢性疼痛患者。 此外，脊髓刺激（SCS）設備的工作原理是向脊髓發送電脈衝並阻止疼痛訊號向大腦的傳輸。

此外，脊髓刺激 (SCS) 設備的技術進步使其變得更小、更靈活且更有效。 例如，較新的設備使用高頻刺激來緩解疼痛，而不會引起與傳統低頻刺激相關的刺痛或刺痛感。 此外，其他進步，例如可充電電池和無線設備的開發，正在提高患者的舒適度和便利性。 隨著患者和醫生尋求更有效、更易於使用的設備，這些技術進步預計將推動對脊髓刺激 (SCS) 設備的需求。

此外，世界人口正在迅速老化，這種人口變化預計將推動對脊髓刺激 (SCS) 設備的需求。 老年人更有可能患有慢性疼痛，隨著人口老化，需要脊髓刺激治療的人數預計會增加。 例如，根據美國人口普查局（2022）的數據，美國有超過 5,600 萬 65 歲及以上的成年人居住，約占美國人口的 16.9%。

目錄

第一章簡介

第 2 章執行摘要

第三章市場概述

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭強度
  • 市場動態
    • 促進因素
      • 慢性疼痛疾病增加
      • 脊髓刺激 (SCS) 設備的技術進步
      • 醫療報銷系統的可用性
    • 抑制因素
      • 脊髓刺激 (SCS) 設備成本高且副作用大
      • 慢性疼痛替代療法的可用性
    • 機會
      • 新興市場的成長機會
  • 新冠肺炎 (COVID-19)：市場影響分析

第 4 章脊髓刺激 (SCS) 設備市場：依產品

  • 摘要
  • 充電
  • 不可充電

第 5 章脊髓刺激 (SCS) 設備市場：依適應症分類

  • 摘要
  • 脊椎手術後疼痛症候群 (FBSS)
  • 複雜性局部疼痛症候群 (CRPS)
  • 退化性椎間盤疾病 (DDD)
  • 其他

第 6 章脊髓刺激 (SCS) 設備市場：依最終使用者劃分

  • 摘要
  • 醫院
  • 門診手術中心
  • 其他

第 7 章脊髓刺激 (SCS) 設備市場：按地區

  • 摘要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲
    • 中東非洲

第八章競爭態勢

  • 簡介
  • 關鍵成功策略
  • 10家主要公司的產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022 年主要公司的定位

第九章公司簡介

  • Boston Scientific Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Nevro Corporation
  • Beijing PINS Medical Co., Ltd
  • Saluda Medical Pty Ltd.
  • Nalu Medical, Inc.
  • Teliatry, Inc.
  • GIMER MEDICAL
  • BIOTRONIK SE & Co. KG
Product Code: A03450

According to a new report published by Allied Market Research, titled, "Spinal Cord Stimulation Devices Market," The spinal cord stimulation devices market was valued at $2.1 billion in 2022, and is estimated to reach $4.8 billion by 2032, growing at a CAGR of 8.4% from 2023 to 2032.

Spinal Cord Stimulation Devices Market - IMG1

The major factors driving the growth of spinal cord stimulation devices market are increase in number of people suffering from chronic pain conditions, technological advancements in spinal cord stimulation devices, and rise in adoption of spinal cord stimulation devices. Chronic pain can be caused by a variety of conditions, such as failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), degenerative disc disease (DDD), and diabetic neuropathy. These conditions can be debilitating, affecting a person's quality of life and requiring long-term management. Spinal cord stimulation devices have emerged as an effective treatment option for patients suffering from chronic pain conditions who have not responded to other forms of therapy. In addition, spinal cord stimulation devices work by delivering electrical impulses to the spinal cord, disrupting the transmission of pain signals to the brain.

Further, technological advancements in spinal cord stimulation devices have made the devices smaller, flexible, and more effective. For instance, newer devices use high-frequency stimulation, which can provide pain relief without causing the tingling or prickling sensations associated with traditional low-frequency stimulation. In addition, other advances include the development of rechargeable batteries and wireless devices, which improve patient comfort and convenience. These technological advancements are expected to drive the demand for spinal cord stimulation devices as patients and physicians seek out more effective and user-friendly devices.

Moreover, the world's population is aging rapidly, and this demographic shift is expected to drive the demand for spinal cord stimulation devices. Older adults are more likely to suffer from chronic pain conditions, and as the population ages, the number of people in need of spinal cord stimulation therapy is expected to grow. For instance, according to the U.S. Census Bureau 2022, more than 56 million adults aged 65 and older live in the U.S., accounting for about 16.9% of the nation's population; thus, rise in geriatric population is anticipated to fuel the growth of market.

The spinal cord stimulation devices market is segmented into product, indication, end user, and region. On the basis of product, the market is bifurcated into rechargeable devices and non-rechargeable devices. Depending on indication, it is categorized into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease, and others. By end user, it is segregated into hospital, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East Africa)

Major key players that operate in the global spinal cord stimulation devices market are Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Beijing PINS Medical Co., Ltd, Saluda Medical Pty Ltd., Nalu Medical, Inc., BIOTRONIK, GIMER MEDICAL, and Teliatry, Inc. The key players have adopted strategies such as acquisition, product launch, product approval, and expansion to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the spinal cord stimulation devices market analysis from 2022 to 2032 to identify the prevailing spinal cord stimulation devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the spinal cord stimulation devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global spinal cord stimulation devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Indication

  • Failed back surgery syndrome
  • Complex regional pain syndrome
  • Degenerative disc disease
  • Others

By Product

  • Rechargeable devices
  • Non-rechargeable devices

By End User

  • Hospitals
  • Ambulatory surgical centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East Africa

Key Market Players:

    • Boston Scientific Corporation
    • Beijing PINS Medical Co., Ltd
    • Medtronic plc
    • Abbott Laboratories
    • BIOTRONIK SE & Co. KG
    • Saluda Medical Pty Ltd.
    • Nalu Medical, Inc.
    • GIMER MEDICAL
    • Teliatry, Inc.
    • Nevro Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of chronic pain conditions
      • 3.4.1.2. Technological advancements in spinal cord stimulation devices
      • 3.4.1.3. Availability of medical reimbursement schemes
    • 3.4.2. Restraints
      • 3.4.2.1. High cost and side effects of spinal cord stimulation devices
      • 3.4.2.2. Availability of alternative treatment options for chronic pain
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Rechargeable devices
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Non-rechargeable devices
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Failed back surgery syndrome
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Complex regional pain syndrome
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Degenerative disc disease
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: SPINAL CORD STIMULATION DEVICES MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory surgical centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Indication
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Product
      • 7.2.5.1.3. Market size and forecast, by Indication
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Product
      • 7.2.5.2.3. Market size and forecast, by Indication
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Product
      • 7.2.5.3.3. Market size and forecast, by Indication
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Indication
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Product
      • 7.3.5.1.3. Market size and forecast, by Indication
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Product
      • 7.3.5.2.3. Market size and forecast, by Indication
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Product
      • 7.3.5.3.3. Market size and forecast, by Indication
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Product
      • 7.3.5.4.3. Market size and forecast, by Indication
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Product
      • 7.3.5.5.3. Market size and forecast, by Indication
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Product
      • 7.3.5.6.3. Market size and forecast, by Indication
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Indication
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Product
      • 7.4.5.1.3. Market size and forecast, by Indication
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Product
      • 7.4.5.2.3. Market size and forecast, by Indication
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Product
      • 7.4.5.3.3. Market size and forecast, by Indication
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Product
      • 7.4.5.4.3. Market size and forecast, by Indication
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Product
      • 7.4.5.5.3. Market size and forecast, by Indication
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Product
      • 7.4.5.6.3. Market size and forecast, by Indication
      • 7.4.5.6.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Indication
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Latin America
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Product
      • 7.5.5.1.3. Market size and forecast, by Indication
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Middle East Africa
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Product
      • 7.5.5.2.3. Market size and forecast, by Indication
      • 7.5.5.2.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Medtronic plc
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Abbott Laboratories
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Nevro Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Beijing PINS Medical Co., Ltd
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Saluda Medical Pty Ltd.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Key strategic moves and developments
  • 9.7. Nalu Medical, Inc.
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Teliatry, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. GIMER MEDICAL
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Key strategic moves and developments
  • 9.10. BIOTRONIK SE & Co. KG
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. SPINAL CORD STIMULATION DEVICES MARKET FOR RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. SPINAL CORD STIMULATION DEVICES MARKET FOR NON-RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 05. SPINAL CORD STIMULATION DEVICES MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. SPINAL CORD STIMULATION DEVICES MARKET FOR COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. SPINAL CORD STIMULATION DEVICES MARKET FOR DEGENERATIVE DISC DISEASE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. SPINAL CORD STIMULATION DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. SPINAL CORD STIMULATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 18. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 20. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 23. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. UK SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. UK SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 39. UK SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 42. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 58. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 61. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 75. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 77. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
  • TABLE 80. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 82. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 83. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 84. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 88. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 90. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 91. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 92. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 93. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 94. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 95. ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 96. NEVRO CORPORATION: KEY EXECUTIVES
  • TABLE 97. NEVRO CORPORATION: COMPANY SNAPSHOT
  • TABLE 98. NEVRO CORPORATION: PRODUCT SEGMENTS
  • TABLE 99. NEVRO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 100. NEVRO CORPORATION: KEY STRATERGIES
  • TABLE 101. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
  • TABLE 102. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
  • TABLE 103. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
  • TABLE 104. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
  • TABLE 105. SALUDA MEDICAL PTY LTD.: KEY EXECUTIVES
  • TABLE 106. SALUDA MEDICAL PTY LTD.: COMPANY SNAPSHOT
  • TABLE 107. SALUDA MEDICAL PTY LTD.: PRODUCT SEGMENTS
  • TABLE 108. SALUDA MEDICAL PTY LTD.: PRODUCT PORTFOLIO
  • TABLE 109. SALUDA MEDICAL PTY LTD.: KEY STRATERGIES
  • TABLE 110. NALU MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 111. NALU MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 112. NALU MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 113. NALU MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 114. TELIATRY, INC.: KEY EXECUTIVES
  • TABLE 115. TELIATRY, INC.: COMPANY SNAPSHOT
  • TABLE 116. TELIATRY, INC.: PRODUCT SEGMENTS
  • TABLE 117. TELIATRY, INC.: PRODUCT PORTFOLIO
  • TABLE 118. GIMER MEDICAL: KEY EXECUTIVES
  • TABLE 119. GIMER MEDICAL: COMPANY SNAPSHOT
  • TABLE 120. GIMER MEDICAL: PRODUCT SEGMENTS
  • TABLE 121. GIMER MEDICAL: PRODUCT PORTFOLIO
  • TABLE 122. GIMER MEDICAL: KEY STRATERGIES
  • TABLE 123. BIOTRONIK SE & CO. KG: KEY EXECUTIVES
  • TABLE 124. BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
  • TABLE 125. BIOTRONIK SE & CO. KG: PRODUCT SEGMENTS
  • TABLE 126. BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
  • TABLE 127. BIOTRONIK SE & CO. KG: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN SPINAL CORD STIMULATION DEVICES MARKET (2023-2032)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALSPINAL CORD STIMULATION DEVICES MARKET
  • FIGURE 10. SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR RECHARGEABLE DEVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR NON-RECHARGEABLE DEVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR COMPLEX REGIONAL PAIN SYNDROME, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR DEGENERATIVE DISC DISEASE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. SPINAL CORD STIMULATION DEVICES MARKET BY REGION, 2022
  • FIGURE 23. U.S. SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. CANADA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. UK SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. ITALY SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. CHINA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. INDIA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP: SPINAL CORD STIMULATION DEVICES MARKET
  • FIGURE 46. TOP PLAYER POSITIONING, 2022
  • FIGURE 47. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 49. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 50. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. NEVRO CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 57. NEVRO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)